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Thyroid hormone plays a critical role in mitochondrial biogenesis in two areas of the developing
brain, the cerebral cortex and the striatum. Here we analyzed, in the cerebral cortex of neonatal
rats, the effect of hypothyroidism on the biogenesis in free and synaptosomal mitochondria by
analyzing, in isolated mitochondria, the activity of respiratory complex I, oxidative phosphoryla-
tion, oxygen consumption, and the expression of mitochondrial genome. In addition, we studied
the effect of thyroid hormone in oxygen consumption in vivo by determining metabolic flow
through 13C nuclear magnetic resonance spectroscopy. Our results clearly show that in vivo, hy-
pothyroidism markedly reduces oxygen consumption in the neural population of the cerebral
cortex. This effect correlates with decreased free mitochondria biogenesis. In contrast, no effect
was observed in the biogenesis in synaptosomal mitochondria. The parameters analyzed were
markedly improved after T3 administration. These results suggest that a reduced biogenesis and
the subsequent reduction of respiratory capacity in free mitochondria could be the underlying
cause of decreased oxygen consumption in the neurons of the cerebral cortex of hypothyroid
neonates. (Endocrinology 150: 3953–3959, 2009)
Thyroid hormones (T4, T3) play an important role in mam-malian tissue development and metabolism. Most of the ac-
tions of these hormones are mediated by the binding of T3 to
specific nuclear receptors that are ligand-dependent transcrip-
tion factors that bind to thyroid hormone response elements in
target genes and regulate transcription initiation (1, 2). These
receptors belong to the nuclear receptor superfamily that is one
of the largest families of transcription factors, which include,
among others, the receptors for steroid hormones, retinoids, vi-
tamin D3, peroxisomal proliferators, and many other transcrip-
tion factors without known ligand (orphan receptors) (1). The
activationof these receptors has been implicated in abroad range
of cellular functions.
The brain is an important target for thyroid hormone action,
particularly during late development, as shown by numerous
clinical and experimental data (3, 4). In the rat brain, the ex-
pression of thyroid hormone receptors increases rapidly after
birth reaching the highest value by d 6 of postnatal life (5, 6). In
agreement with this, during the perinatal period, the conse-
quences of hypothyroidism are more dramatic and results in
numerous alterations, such as reduction in dendritic arboriza-
tion of cerebellar Purkinje cells; impairment of nerve process
development; poor connectivity among neurons; changes in mi-
crotubule content; and impaired myelin deposition, cell migra-
tion, and synaptogenesis (4).
Themitochondria arewell-established targets of thyroid hor-
mone action. The regulation by thyroid hormone of mitochon-
drial activity and biogenesis are extensively documented in nu-
merous mammalian tissues such as liver, kidney, heart, and
muscle (7). In these tissues the administration of T3 increases
oxygen consumption and oxidative phosphorylation, which un-
derlies the calorigenic effect of this hormone. In the case of the
brain, after initial contradictory reports (8–11), it is now well
established that themitochondria are targets of thyroidhormone
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action at least during development. In the brain of neonatal rats
the expression of mitochondrial genes encoded both in nuclear
and mitochondrial genomes is regulated by thyroid hormones
(12). We have also demonstrated that congenital hypothyroid-
ism decreases rhodamine 123 uptake, alters mitochondrial mor-
phology (13), and decreases respiratory complex I activity and
oxidative phosphorylation capacity in the presence of nicotin-
amide adenine dinucleotide (NADH)-generating substrates (14).
These effects of thyroid hormone are dependent of the brain area
analyzed, being the mitochondria in the cerebral cortex and the
striatum sensitive to the action of this hormone (14). These re-
sults suggest that, in the developing rat, thyroid hormone regu-
latesmitochondrial biogenesis through the control of the expres-
sion ofmitochondrial genes and in consequence also controls the
capacity of oxidative phosphorylation in specific regions of the
brain such as the cerebral cortex and striatum. Two different
mitochondrial fractions can be easily isolated from nervous tis-
sues: free and synaptosomal. The synaptosomal fraction is un-
equivocally from neuronal origin, and consequently, any effect
of thyroid hormone on this mitochondrial fraction could easily
be ascribed to the neuronal population. In addition, the impor-
tant role played by synaptosomal mitochondria in neurotrans-
mitter releasemakes the analysis of the possible action of thyroid
hormone more relevant.
In vivo and in vitro 13C nuclear magnetic resonance (NMR)
approaches have been found to provide comprehensive infor-
mation on cerebral metabolism, mainly in the metabolic com-
partmentation of glutamate, glutamine, and -aminobutyric acid
(GABA) (15–17). High-resolution ex vivo 13CNMR spectroscopy
after in vivo infusion of (1-13C) glucose can be used to evaluate
changes throughmetabolic pathways andalsoprovide insights into
thecellular localizationof these changes thanks to theuseof specific
inhibitors such as trifluoroacetic acid (TFA), a well-known inhib-
itor of the glial tricarboxylic acid (TCA) cycle (18).
In this work we analyzed, in the cerebral cortex of neonatal
rats, the effect of thyroidal state on the biogenesis in free and
synaptosomal mitochondria and on oxygen consumption. To
achieve these goals, we determined in isolated free and synap-
tosomal mitochondria the expression of mitochondrial genome,
the activity of respiratory complex I, the capacity of oxidative
phosphorylation and respiration, and in vivo the metabolic flow
through the TCA cycle, as a measure of oxygen consumption,
using 13C NMR spectroscopy. Our results clearly show that the
biogenesis of synaptosomal mitochondria is not dependent on
thyroidal state. In contrast, the biogenesis of free mitochondria
and also the oxygen consumption in vivo were dramatically de-
creased in the cerebral cortex of hypothyroid neonates.
Materials and Methods
Materials
Methyl mercaptoimidazole, T3, glutamate, malate, succinate, pyru-
vate, ADP, ATP, D-luciferin, luciferase, and TFA were obtained from
Sigma Chemical Co. (St Louis, MO); (1-13C) glucose (99.9% 13C) was
obtained from Cambridge Isotope Laboratories (Andover, MA) and
2H2O(99.9%
2H) fromApollo Scientific Ltd. (Stockport,Cheshire,UK).
All other chemicals were reagent grade or molecular biology grade.
Animal treatment
All animal related procedures were approved by the Laboratory An-
imal Care and Use Committee of the Universidad Complutense de Ma-
drid and were conducted in accordance with the guidelines of the Eu-
ropean Communities Council, directive 86/609/EEC. All efforts were
made to minimize animal suffering and reduce the number of animals
used. Female Wistar rats were mated and the day of appearance of the
vaginal plug was considered as d 0 of fetal age. To induce fetal and
neonatal hypothyroidism, damswere given 0.02%methylmercaptoimi-
dazole in the drinking water at d 12 of gestation. Methyl mercaptoimi-
dazole treatment was continued throughout the whole period of the
experiment. This protocol ensures that the animals are hypothyroid
throughout the neonatal age, as shown by the decrease growth rate and
circulating levels of T3 in 15-d-old neonates below the level of detect-
ability. To determine reversibility of the effects caused by hypothyroid-
ism treatment, half of the hypothyroid animals were daily injected with
20g T3 per 100 g of bodyweight during 3 d (starting at postnatal d 12),
a treatment shown to normalized mitochondrial activity (14). During
this period the remaining animals received an ip injection of the same
volume of saline. Except for the 13C NMR spectroscopy studies, the
animals were killed by decapitation at postnatal d 15, and the brain was
quickly removed and the cerebral cortex dissected for free and synap-
tosomal mitochondria isolation. All the rats used in this study were
housed in a humidity- and temperature-controlled room on a 12-h light,
12-h dark cycle, receiving water and food ad libitum.
Isolation of mitochondria
Cerebral cortex tissue was minced and homogenized manually in
0.32 M sucrose, 1 mM EDTA, 10mMTris-HCl (pH 7.4), and 0.1%BSA,
centrifuged at 2000 g for 4min. The precipitate was discarded and the
supernatant was centrifuged again at 12,500  g for another 10 min.
This precipitate was resuspended and free and synaptosomal mitochon-
dria were isolated in Ficoll and Percoll gradients according to the pro-
cedures described by Lai et al. (19) and Dunkley et al. (20) respectively.
The mitochondria were finally resuspended in the appropriate experi-
mental solutionwithoutBSAandprotein contentwasmeasuredbyBrad-
ford’s procedure using BSA as standard.
ATP production and respiratory complex I activity
Isolated mitochondria were incubated at 22 C in incubation media
[45 mM sucrose, 100 mM KCl, 10 mM Tris-HCl (pH 7.5), 5 mM MgCl2,
10 mM KH2PO4 and 0.5% BSA] with ADP (0.5 mM) and the following
substrates: glutamate/malate (5 mM each) or succinate (5 mM). Samples
were collected after 2, 4, 6, and 8 min of incubation and the amount of
ATP determined by the luciferin/luciferasemethod (21). The rate of ATP
synthesis was calculated with the straight line obtained by representing
ATP concentration against time.
The activity of the rotenone-sensitive NADH-coenzyme Q1 reduc-
tase (complex I) was determined as previously described (22).
Oxygen consumption
Oxygen consumption in freshly prepared mitochondria was mea-
sured polarographically with a Clark-type electrode (Oxigraph Hansat-
ech, Norfolk, UK) at 30 C with constant stirring. Mitochondria (0.7 mg
of protein) were suspended in 1 ml of respiratory medium [75 mM su-
crose, 50 mMKCl, 5 mMKH2PO4, 0.5 mM EDTA, 5 mMMgCl2, and 30
mM Tris-HCl (pH 7.4)] and the basal rate of respiration (state 4) deter-
mined in the presence of diverse substrates: glutamate/malate (5 mM
each), pyruvate/malate (5 mM each), or succinate (5 mM). When succi-
nate was the substrate, 5 M rotenone was also added. The active state
of respiration (state 3) was initiated by the addition of 0.5mMADP (22).
Mitochondrial gene expression
For total mitochondrial RNA and DNA extraction, 400 g of mi-
tochondrial protein were digested with proteinase K (6 g/ml) at 37 C
during 30 min in extraction media [LiCl 0.5M, urea 1 M, 1% sodium
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dodecyl sulfate, 2.5 mM EDTA, and 20 mM sodium citrate (pH 8)];
organic extracted; and the nucleic acids precipitated, resuspended in
diethylpyrocarbonate water, and its integrity analyzed and quantified.
cDNA was synthesized with the RETRoscript kit (Ambion, Austin,
TX) using 2 g of total nucleic acids and the downstream oligonucleo-
tides used in PCR. In parallel a mock cDNA synthesis reaction (without
reverse transcriptase) was performed for each sample. Real-time PCR
was performed in an ABI Prism equipment using the SYBR Green PCR
master mix (Applied Biosystems, Warrington, UK), 5 l of mitochon-
drial nucleic acid, and300nMconcentrationsof specific primers in a final
volume of 25 l. Cycle threshold (Ct) values were calculated from the
strait line created using different dilutions of sample. The primers used
for thedeterminationof the concentrationof the transcripts of 12S rRNA
and ND4 mRNA were: 12S, TCGATAAACCCCGTTCTACCTTAC
and TGGTGATGATGGCGGTATATAGG, which amplified a frag-
ment of 80 bp (from nucleotide 564 to 640 of the rat mitochondrial
DNA) andND4, AATAATCGCCCACGGCTTAAC and TTCGTTCG-
TAGTTGGTGTTTGC, which amplified a fragment of 65 bp (from nu-
cleotide 11101 to 11166 of the rat mtDNA). The concentration of
mtDNA was determined by measuring D loop, GCATGAAGGTCAG-
CACAAAGTC and TCGAGCTTTGTCTATGAGGATAAATG. The
difference betweenCt values of real andmock cDNAsynthesiswere used
as a measure of gene expression in each sample. As expected, the same
Ct values were obtained with mock and real cDNA synthesis when the
D loop oligonucleotideswere used for amplification. The final values are
the average SE of the determination in at least five different samples and
are normalized by the values found in the mitochondria of control
animals.
13C NMR spectroscopy studies
At least five animals per group were infused under deep anesthesia
(1–2% of isoflurane in 1 liter/min O2 through a nose cap). The infusion
was performed through the jugular vein with (1-13C) glucose (8 mol
min1/g1) during 60 min. Sodium TFA was coinfused (24 mol/
min1  g1) with (1-13C) glucose (23). The physiological state of the
animal was constantly monitored, and blood samples were taken before
and immediately after infusion for glucose levels determination. The
metabolism of the rat brain was arrested using a microwave fixation
system (Muromachi Kikai Co. Ltd., Tokyo, Japan), the brain rapidly
removed, and the cerebral cortex dissected and frozen in liquid N2. Per-
chloric acid extracts were prepared, neutralized with KOH, lyophilized,
and resuspended in 99.9% 2H2O. High-resolution
13C NMR spectros-
copy and the quantification of absolute amount of 13C incorporated in
the different carbons was performed in a AVANCE 500WBNMR spec-
trometer (Bruker, Ettlingen, Germany) using a commercial (5mm) triple
resonance probe (1H, 13C, 2H) optimized for direct 13C NMR detection
(24, 25). The unchanged myo-inositol was used as a robust reference
fromwhich all 13C resonances can be normalized (25, 26). Additionally,
myo-inositol is a good internal reference once its resonances do not
change with thyroid status (25).
High-resolution proton-decoupled 13C NMR spectra were obtained
at 11.7 Tesla as described (16) and the absolute amount of 13C incor-
porated in the different carbons and the fractional enrichment was de-
termined as previously described (23, 26, 27).
Quantification of metabolite concentrations
The amino acid content of brain extracts was determined with an
automatic amino acid analyzer Biochrom 20 (Pharmacia, Uppsala, Swe-
den) using a cationic exchange column and precolumn derivatization
with ninhydrin as previously described (23).
Statistical analysis
Statistical analysis was performed using the SPSS package (SAS In-
stitute Inc., Cary, NC).When indicated, the statistical significance of the
differences was assessed using the Student’s t test. The threshold for
statistical significance was set at P  0.05.
Results
Congenital hypothyroidism does not alter oxidative
phosphorylation and complex I activity in isolated
synaptosomal mitochondria
Prior to the study of synaptic mitochondria function, we first
analyzed the purity of synaptosomal fraction by electronic mi-
croscopy and flow cytometry (13). No differences were found
between the synaptosomal fractions from the cerebral cortex of
control and hypothyroid neonates. The percentage of particles
microscopically identified as synaptosomes (presenceof synaptic
vesicles) and free mitochondria were approximately 60 and
10%, respectively, and cytometric analysis showed that 80% of
the particles were positive for the anti syntaxin antibody in both
groups of animals (data not shown). These results exclude any
major interference of free mitochondria or other unwanted con-
taminants in later comparison of the activity of synaptosomal
mitochondria between control and hypothyroid animals. In ad-
dition to this, the activity of citrate synthasewas used as an index
of purity in freemitochondrial fractions, and no differenceswere
found between control and hypothyroid animals (data not
shown). Oxidative phosphorylation studies show that in synap-
tosomalmitochondria, aspreviously shown in freemitochondria
(14), ATP accumulates linearly in the experimental conditions
used (Fig. 1A), andmore importantly, no differences were found
in the rate of ATP synthesis between control and hypothyroid
mitochondria in the presence of glutamate/malate or succinate
(complex I and complex II substrates) (Fig. 1B). The lack of
differences in the presence of complex I substrates is clearly in
contrast with the marked decrease (48%) in the rate of ATP
synthesis previously observed by our group in the freemitochon-
dria from the cerebral cortex of hypothyroid animals (14). This
lack of difference suggests that we should not find any difference
in the activity of complex I between synaptosomalmitochondria
from control and hypothyroid neonates. On the contrary, and in
FIG. 1. Hypothyroidism does not alter oxidative phosphorylation in
synaptosomal mitochondria. Synaptosomal mitochondria were obtained from the
cerebral cortex of N15 (15 d old) control and hypothyroid rats and the oxidative
phosphorylation capacity analyzed as indicated in Materials and Methods. A, A
representative experiment of linear accumulation of ATP in a sample of control
mitochondria in the presence of glutamate/malate (Glu/Mal) as substrates. B,
Phosphorylation rate in the presence of different substrates. The values are the
average of at least five different samples, and the bars represent the SEs.
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accordance with previous results (14), we should find a clear
difference in free mitochondria. Then, to clarify this point, we
compared complex I activity in isolated free and synaptosomal
mitochondria from the cerebral cortex of control and hypothy-
roid animals. As shown in Fig. 2A, no differences were observed
in complex I activity in the synaptosomal fraction between con-
trol and hypothyroid animals. In contrast, a marked decrease
(50–60%) was observed in the free mitochondria fraction from
the same group of hypothyroid animals (Fig. 2A).
Congenital hypothyroidism decreases respiration only in
isolated free mitochondria
These results suggest that a decreased capacity in oxygen con-
sumption shouldbe foundonly in the freemitochondrial fraction
of hypothyroid animals andonly in the presence of complex I but
not in the presence of complex II substrates. Thenwe next tested
this hypothesis and, as shown in Fig. 2B, a decrease in oxygen
consumption was observed only in the free mitochondrial frac-
tionof the cerebral cortexof hypothyroid animals in thepresence
of complex I substrates, glutamate/malate (36%), and pyruvate/
malate (50%), whereas no differences were detected in the pres-
ence of the complex II substrate succinate. Regarding synapto-
somal mitochondria, we did not find any
significant difference with any of the sub-
strates analyzed (Fig. 2B).
Congenital hypothyroidism alters
mitochondrial gene expression only in
free mitochondria
As suggested in a previouswork fromour
laboratory, alterationofmitochondrial gene
expression could be the leading cause of mi-
tochondrial dysfunction observed in the hy-
pothyroid animals (14). Consequently, al-
terations in mitochondrial gene expression
in the cerebral cortex should be specific of
freemitochondria.We tested this hypothesis
by analyzing the content of ND4 and 12S
transcripts in both fractions of mitochon-
dria from control and hypothyroid neo-
nates. As can be observed in Fig. 3 a decrease
in 12S rRNA and ND4 mRNA (60% in
both cases) was observed in the free mito-
chondria of hypothyroid animals andnodif-
ferences were detected in the synaptosomal
fraction.
Congenital hypothyroidism reduces, in
intact neonatal rats, the metabolic flow
through TCA cycle in the neuronal
population of the cerebral cortex
The lack of effect of hypothyroidism spe-
cificallyon thebiogenesis andactivity in syn-
aptic mitochondria could be interpreted in
different ways. It could be possible that only
the biogenesis in glial, but no neuronal mi-
tochondria is under the control of thyroid
hormone.However,we think that this explanation is improbable
because the glial mitochondrial volume is too small (28) to ac-
count for the described effect of hypothyroidism (14), and con-
sequently, the neuronal mitochondria is most likely implicated.
Therefore, tobetter address thequestionof cell types affected,we
analyzed the respiratory activity in the neuronal population of
the cerebral cortex in vivo. To do so, we measured the incorpo-
ration of 13C from (1-13C)-glucose into glutamateC4, glutamine
C4, and GABA C2 in the presence of TFA, a potent glial TCA
cycle inhibitor (18). Figure 4A shows representative high-reso-
lution 13C NMR spectra obtained from perchloric acid extracts
of brains from control, hypothyroid andT3-treated hypothyroid
rats. A comparison of all the spectra indicates that the 13C from
the (1-13C)glucosehasbeen selectively incorporated into specific
cerebral metabolites, like glutamate, glutamine, GABA, alanine,
and aspartate. In contrast, myoinositol carbons were not notice-
ably de novo labeled because myo-inositol had a low turnover
and did not become enriched after 60 min (1-13C) glucose infu-
sion. Figure 4B summarizes the amounts of 13C incorporated in
the 13C NMR observable carbons of glutamate, glutamine, and
GABA in the three groups of animals studied. Congenital hypo-
thyroidism reduced 60–70% 13C incorporation from (1-13C)
FIG. 2. Differential effect of hypothyroidism on complex I activity and oxygen consumption in free and
synaptosomal mitochondria. Free and synaptosomal mitochondria were obtained as described from the
cerebral cortex of N15 control and hypothyroid rats, and the activity of complex I and oxygen consumption
were analyzed as indicated in Materials and Methods. A, Rate of complex I activity (NADH oxidized). B,
Oxygen consumption in the presence of different substrates. The values are the average of at least five
different samples, and the bars represent the SEs. *, P  0.05; **, P  0.01; ***, P  0.001 vs. the
corresponding control. Glu/Mal, Glutamate/malate.
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glucose in the carbons investigated: glutamateC4, glutamateC4,
and GABA C2, reflecting a decrease in the de novo synthesis of
these amino acids from (1-13C) glucose. After the T3 treatment,
the incorporation of 13C returned to values close to those ob-
tained in the control animals in virtually all carbons investigated,
indicating that thyroidhormone clearly improvedneuronalTCA
cycle flow. Figure 4C shows the total cerebral amounts of these
metabolites under the different experimental conditions used. T3-
treated animals present slight increases in the total cerebral gluta-
mate, glutamine, alanine, andaspartate concentrations.GABAwas
not significantly affectedbyT3 treatment.Valuesof combined frac-
tional 13C enrichment are depicted in Fig. 4D, showing a very sim-
ilar behavior to that shown in the 13C incorporation results.
Changes in the fractional 13C enrichment are represented because
they reflect thedenovo synthesis of aminoacids,whereas increased
total amount of 13C in amino acids might also be due to reduced
amino acid turnover. No differences were observed in the
plasma levels of glucose neither before nor after glucose in-
fusion (3.2  0.9 and 3.8  0.7 mM before and 30  3.6 and
36.6  2.4 mM after glucose infusion in control and hypo-
thyroid animals, respectively), therefore indicating that the
(1-13C) glucose was not differently diluted by endogenous
glucose to explain the decrease in apparent flow in TCA cycle.
These results clearly show that the activity of neuronal mito-
chondrial is under the control of thyroidhormone. Similar absolute
values and differences among the three experimental groups were
observedwhenTCAcycle flowwasmeasured in theabsenceofTFA
(glial plus neuronal TCA cycle flow) (data not shown).
Discussion
In this work we have shown that the biogenesis and respiratory
capacity in freemitochondria are decreased in the cerebral cortex
of hypothyroid neonates, whereas no differences were observed
FIG. 3. Differential effect of hypothyroidism on mitochondrial gene expression in
free and synaptosomal mitochondria. Total mitochondrial nucleic acids were isolated
from free and synaptosomal mitochondria from the cerebral cortex of control and
hypothyroid N15 rats and the relative amount of ND4 and 12S rRNA determined.
Values are normalized to the corresponding controls and represent the average of
determinations in at least five different samples. Bars represent the SE. ***, P 0.001.
FIG. 4. Congenital hypothyroidism decreases metabolic flow through neuronal TCA cycle. A, Expansions of representative proton-decoupled 13C NMR spectra of extracts
from the cerebral cortex of control, hypothyroid and T3-treated hypothyroid rats infused with (1-
13C) glucose. Only the 16–57- and 71–76-ppm regions are shown. Ac,
Acetate; Ala, alanine; Asp, aspartate; Glu, glutamate; Gln, glutamine; NAA, N-acetylaspartic acid; PCr, phosphocreatine; tau, taurine; PPM, parts per million. Asterisks indicate
peaks that were significantly different among groups. B, 13C-label incorporation in some individual carbon positions after infusion of (1-13C) glucose. C, Cortical tissues content
of diverse amino acids in the same extracts used for 13C NMR. D, Combined fractional 13C enrichment of glutamate, glutamine, and GABA, determined as indicated. Values
are the average of at least the determination in five different samples, and the bars represent the SE. *, P 0.05 vs. control; #, P 0.05 vs. hypothyroid.
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in the behavior of synaptosomal mitochondria between control
and hypothyroid animals. In parallel we observed that the met-
abolic flow through neuronal TCA cycle is markedly reduced,
being all these changes almost completely reversed by the ad-
ministration of T3.
The metabolic flow through the TCA cycle is tightly coupled
to the activity of the mitochondrial respiratory chain, and there-
fore, the rate of oxygen consumption can be inferred from the
rate of TCA cycle using known stoichiometry (17). Our results
showing a 60–70% decreased 13C incorporation from (1-13C)
glucose suggest that a 60–70%decrease in oxygen consumption
takes place in the neuronal population of the cerebral cortex of
hypothyroid neonatal rats. These results shed light on the ap-
parently contradictory results previously published concerning
the effect of thyroid hormone on brain oxygen consumption in
neonatal rats. Initial reports showed that the administration of
thyroid hormone to developing animals increases oxygen con-
sumption in brain slices (8, 10). However, later data failed to
confirm these results in isolatedmitochondria andbrain slices (9,
11). The results obtained in the present study represent a signif-
icant advance over the above-mentioned studies because they
have been performed in vivo.
Previous reports implicated thyroid hormone in mitochondrial
biogenesis in the developing brain (12–14, 29, 30). Specifically, we
have shown that hypothyroidismdecreasesmitochondrial gene ex-
pression (12), alters themorphologyofmitochondriaanddecreases
mitochondrial membrane potential (13) and oxidative phosphor-
ylation capacity (14) in the brain of neonatal rats. We have also
demonstrated that these effects depend on the area of the brain
analyzed, being the cerebral cortex a very sensitive area (14). These
effects of thyroid hormone on mitochondrial biogenesis could ob-
viously underlay, or at least play an important role, in the observed
decrease in in vivo respiration shown in this work. In addition to
this, other factors could also contribute to the observed decrease in
oxygen consumption. In this sense it is interesting to point out that
the synaptic density is decreased in the cerebral cortex of hypothy-
roid rats (4), and consequently, a reduction in synaptic activity and
the subsequence reduction in energydemands couldbeoneof those
other factors.
In the present study, in addition to assessing the metabolic
flow through the TCA cycle, usually considered a measurement
of respiratory activity, in neurons of the cerebral cortex of neo-
natal rats in different thyroidal states in vivo, we have analyzed
in detail the biogenesis and respiratory activity in the synapto-
somal and freemitochondrial fractions.Our results clearly show
that hypothyroidism decreases gene expression, complex I ac-
tivity, oxidative phosphorylation, and respiratory capacity only
in free mitochondria, being the synaptosomal fraction unaf-
fected by the thyroidal state. In agreement with previous data
(14), the biogenesis of respiratory complex I seems to be critical
for the action of thyroid hormone and only a decrease in oxida-
tive phosphorylation and respiration was observed in free mito-
chondrial in the presence of complex I substrates, such as glu-
tamate/malate and pyruvate/malate, but not in the presence of
succinate, suggesting that no other respiratory complexwas crit-
ically reduced. In this sense is interesting to note that a decrease in
complex I activity is the most frequent dysfunction of the respira-
tory chain observed in mitochondrial pathologies (31, 32).
The administration of T3 to hypothyroid animals almost ab-
rogated the decrease in in vivo respiration and the other mito-
chondrial deficits observed in these animals (14). Interestingly,
although the dose of T3 used was higher than the physiological
one, all mitochondrial parameters analyzed returned to control
values 72 h after T3 administration, as previously shown for
oxidative phosphorylation, complex I activity, and mitochon-
drial gene expression (14).This situation is different fromtheone
observed in other tissues in which mitochondrial function is under
thyroid control, such as liver, in which administration of pharma-
cological levels of T3 increases oxygen consumption well above
control values (11). This is probably the consequence of the high
receptor occupancy found in the brain of control animals (33).
The differential regulation by thyroid hormone of mitochon-
drial biogenesis in synaptosomaland freemitochondria shown in
this paper further supports the already well-established differ-
ences between these two mitochondrial fractions in TCA cycle
enzymes, respiratory activity, and lipid composition (34–37).
Free mitochondria are the sum of glial plus neuronal (those in
dendrites and body) mitochondria; therefore, the observed dif-
ferences in this fraction between control and hypothyroid neo-
nates could be due to cell type differences, glia vs. neurons. We
do not think that our findings necessarily reflect a difference
between neuronal and glial cells. We discount this possibility on
the grounds that the glial mitochondrial volume is too small (28)
to account for the extensive differences observed. Instead we
suggest that the differential regulation noted here is a conse-
quence of the mitochondrial heterogeneity that can be found
within the neuronal population (38, 39). However, the precise
mechanism underlying this differential response to thyroid hor-
mone between free and synaptosomal mitochondrial remains to
be ascertained. In this regard it is interesting that in cultured
dorsal root ganglia neurons, Miller and Sheetz (40) have shown
that high potential mitochondria are preferentially transported
toward the growth cone. Taking into account our previous ob-
servation that the average transmembrane potential is reduced in
free mitochondria of the brain of N15 hypothyroid rats and that
the mitochondrial population is heterogeneous with both low-
and high-potential mitochondria (13), it is tempting to speculate
that the mechanism proposed by Miller and Sheetz (40), if op-
erative in the cerebral cortex of the rat, could prevent or reduce
the location ofmitochondriawith lower potential, and probably
lower complex I activity, in presynaptic terminals. In addition to
this, several transcription factors have also been described to be
present in the mitochondrial matrix (41), which could mediate
the regulation ofmitochondrial gene expression by the local pro-
duction of different mediators (42).
In summary, our results clearly show that in hypothyroid neo-
nates therespiratoryactivity isdecreasedintheneuronalpopulation
of the cerebral cortex. This effect is accompanied by a decrease in
mitochondrial biogenesis specifically in free mitochondria, as
shown by reduced mitochondrial gene expression, complex I ac-
tivity, and respiration and oxidative phosphorylation in hypothy-
roidanimals.Wehypothesize that theeffectof thyroidhormoneson
free mitochondrial biogenesis could underlay their effects on res-
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piration. Finally, the results presented in this paper are particularly
important in the light of growing evidence showing an implication
of mitochondrial alteration in diverse neurological pathologies,
particularly in neurodegenerative diseases (43).
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